The effect of R&D capitalization on revenue-expense matching: Focusing on the bio-pharmaceutical industries in South Korea
-
DOIhttp://dx.doi.org/10.21511/imfi.22(1).2025.17
-
Article InfoVolume 22 2025, Issue #1, pp. 213-230
- 16 Views
-
1 Downloads
This work is licensed under a
Creative Commons Attribution 4.0 International License
The study aims to investigate the effect of research and development (R&D) capitalization on revenue-expense matching in the pharmaceutical and biotechnology industries, with particular attention to the moderating role of corporate governance and the influence of regulatory intervention. While capitalizing R&D expenditures enhances the relevance of financial information and positively impacts firm value, it also increases the risk of earnings management, potentially disrupting revenue-expense matching. Using a fixed-effects regression model, this study analyzes 1,350 firm-year observations from Korean listed firms in the bio-pharmaceutical sector from 2012 to 2022. The sample includes firms with financial statements, auditor data, and detailed disclosures on R&D expenditures, encompassing capitalized R&D costs, R&D expenses recognized in income statements, and those classified as manufacturing costs. The results indicate that R&D capitalization generally weakens revenue-expense matching in these industries. However, the adverse effects are mitigated by the effective implementation of corporate governance mechanisms. Additionally, the Financial Supervisory Service’s thematic supervision of R&D accounting practices has significantly improved revenue-expense matching. Prior to the supervision period (2012–2017), firms exhibited significant discretionary capitalization practices, undermining revenue-expense matching. Following the supervision (2018–2022), improved adherence to accounting standards has enhanced matching quality, underscoring the regulatory intervention’s effectiveness. These findings contribute to the literature by demonstrating that while discretionary R&D capitalization can impair revenue-expense alignment, strong corporate governance and adherence to accounting standards can offset these negative effects. The study provides valuable implications for future research and industry practices, particularly in navigating the trade-offs associated with R&D capitalization.
Acknowledgment
This study was supported by Chungnam National University.
- Keywords
-
JEL Classification (Paper profile tab)O32, M41, G32, M40
-
References38
-
Tables8
-
Figures0
-
- Table 1. Sample selection process and annual distribution of samples
- Table 2. Descriptive statistics
- Table 3. Correlations (p-values below)
- Table 4. The effect of R&D capitalization on the revenue-expense matching
- Table 5. The moderating effect of the outside directors on the relationship between R&D capitalization and revenue-expense matching
- Table 6. The moderating effect of the largest shareholder’s ownership on the relationship between R&D capitalization and revenue-expense matching
- Table 7. The effect of R&D capitalization on the revenue-expense matching before and after the thematic supervision by the FSS
- Table A1. Variable definition
-
- Ashbaugh-Skaife, H., Collins, D. W., & LaFond, R. (2006). The effects of corporate governance on firms’ credit ratings. Journal of Accounting and Economics, 42(1-2), 203-243.
- Badolato, P. G., Donelson, D. C., & Ege, M. (2004). Audit committee financial expertise and earnings management: The role of status. Journal of Accounting and Economics, 58(2-3), 208-230.
- Biddle, G. C., Hilary, G., & Verdi, R. S. (2009). How does financial reporting quality relate to investment efficiency? Journal of Accounting and Economics, 48(2-3), 112-131.
- Byrd, J. W., & Hickman, K. A. (1992). Do outside directors monitor managers? Evidence from tender offer bids. Journal of Financial Economics, 32(2), 195-221.
- Callimaci, A., & Landry, S. (2004). Market valuation of research and development spending under Canadian GAAP. Canadian Accounting Perspectives, 3(1), 33-53.
- Chen, J. Z., Cussatt, M., & Gunny, K. A. (2020). When are outside directors more effective monitors? Evidence from real activities manipulation. Journal of Accounting, Auditing & Finance, 35(1), 26-52.
- Cho, S., & Choi, H. (2021). Managerial ability and revenue-expense matching: Accrual estimation versus real business decision. Asia-Pacific Journal of Accounting & Economics, 1-16.
- Core, J. E., Holthausen, R. W., & Larcker, D. F. (1999). Corporate governance, chief executive officer compensation, and firm performance. Journal of Financial Economics, 51(3), 371-406.
- Darrough, M., & Rangan, S. (2005). Do insiders manipulate earnings when they sell their shares in an initial public offering? Journal of Accounting Research, 43(1), 1-33.
- Deutsch, Y. (2007). The influence of outside directors’ stock-option compensation on firms’ R&D. Corporate Governance: An International Review, 15(5), 816-827.
- Dichev, I. D., & Tang, V. W. (2008). Matching and the change properties of accounting earnings over the last 40 years. The Accounting Review, 83(6), 1425-1460.
- Donelson, D. C., Jennings, R., & McInnis, J. (2011). Changes over time in the revenue-expense relation: Accounting or economics? The Accounting Review, 86(3), 945-974.
- Fama, E. F., & Jensen, M. C. (1983). Separation of ownership and control. The Journal of Law and Economics, 26(2), 301-325.
- Financial Services Commission of Korea. (2018). Guidelines on the accounting treatment of R&D expenses for pharmaceutical and bio companies.
- Han, B. (2010). Factors affecting R&D intensity and capitalization. Korean Accounting Journal, 19(5), 185-219.
- Hyun, J. H., & Cho, H. (2018). Deleveraging and decline in revenue-expense matching over time. Journal of Business Finance and Accounting, 45(9-10), 1031-1050.
- Jensen, M., & Meckling, W. (1976). Theory of the firm: Managerial behavior, agency costs and ownership structure. Journal of Financial Economics, 3(4), 305-360.
- Kang, Y., & Choi, S. (2020). Case study on accounting for R&D expenses of pharmaceutical and bio companies: Focusing on the case of Helix Smith. Korea Business Review, 24(3), 77-103.
- Kim, J. (2013). Effect of earnings management on the principle of matching costs with revenue. Journal of Taxation and Accounting, 14(3), 9-28.
- Kim, M. (2016). The effect of the capitalization of research and development expenditures on earnings management in medical firms. Journal of Finance and Accounting Information, 16(1), 79-98.
- Klein, A. (2002). Audit committee, board of director characteristics, and earnings management. Journal of Accounting and Economics, 33(3), 375-400.
- Korea Institute for Advancement of Technology. (2023). Industrial R&D investment scoreboard.
- Lee, A. Y., Chun, S. B., & Kim, S. H. (2012). Controlling shareholders’ ownership structure and real earnings management. Korean Accounting Review, 37(1), 157-189.
- Lev, B., & Sougiannis, T. (1996). The capitalization, amortization, and value-relevance of R&D. Journal of Accounting and Economics, 21(1-2), 107-138.
- Lev, B., & Zarowin, P. (1999). The boundaries of financial reporting and how to extend them. Journal of Accounting Research, 37(1), 353-385.
- Markarian, G., Pozza, L., & Prencipe, A. (2008). Capitalization of R&D costs and earnings management: Evidence from Italian listed companies. The International Journal of Accounting, 43(3), 246-267.
- Morck, R., Shleifer, A., & Vishny, R. (1988). Management ownership and market valuation: An empirical analysis. Journal of Financial Economics, 20(1), 293-315.
- Paek, W. S. (2011). The change in accounting environment and the matching principle. Korean Management Review, 40(1), 29-49.
- Park, J. (2003). Corporate governance and earnings management: View from the largest shareholder’s holding. Korean Accounting Review, 28(2), 135-172.
- Peasnell, K. V., Pope, P. F., & Young, S. (2005). Board monitoring and earnings management: Do outside directors influence abnormal accruals? Journal of Business Finance & Accounting, 32(7-8), 1311-1346.
- Roychowdhury, S. (2006). Earnings management through real activities manipulation. Journal of Accounting and Economics, 42(3), 335-370.
- Son, K., & Choi, W. (2012). Earnings management using the discretionary evaluation of the realizability of deferred tax assets. Korean Journal of Taxation Research, 29(1), 239-282.
- Song, C., Um, I. C., Kim, S. N., & Yi, W. (2024). A study on the overview and enhancing efficiency of government R&D in drug development (KISTEP Issue Paper No. 359). Korea Institute of Science and Technology Evaluation and Planning.
- Srinivasan, S. (2005). Consequences of financial reporting failure for outside directors: Evidence from accounting restatements and audit committee members. Journal of Accounting Research, 43(2), 291-334.
- Srivastava, A. (2014). Why have measures of earnings quality changed over time? Journal of Accounting and Economics, 57(2-3), 196-217.
- Wyatt, A. (2005). Accounting recognition of intangible assets: Theory and evidence on economic determinants. The Accounting Review, 80(3), 967-1003.
- Yang, S., & Im, J. (2021). The effect of theme audit review on R&D accounting: Focusing on bio-pharmaceutical industries. Korean Accounting Review, 46(5), 235-279.
- Yoon, B., & Kim, W. (2008). The impact of ownership structure on the value relevance of R&D investment in KOSDAQ firms. Korea International Accounting Review, 24, 75-97.